Lynxcare

LynxCare is the Big Data market leader in healthcare. Thanks to an AI-driven data platform, they help hospitals unlock previously unavailable clinical data for better patient care and scientific research. After all, this data shows the actual outcome of treatments, a reality that may differ from what clinical studies indicate.

LynxCare was founded in 2015 by (pharmacist) Georges De Feu and (physician) Dries Hens. Today, the company is a fast-growing Belgian scale-up. It currently employs 35 people, including doctors, biomedical scientists, data specialists and more than 10 researchers (PhD).

They work for leading hospitals in Europe and in the United States and facilitate scientific research for Life Sciences companies such as AstraZeneca, Pfizer, Novartis. Within a strict ethical and legal framework, LynxCare helps these hospitals make sense of their vast amount of data using AI (artificial intelligence) and NLP (Natural Language Processing) to unlock these new insights, called “Real-World Evidence”.

LynxCare is raising EUR 20 million in a Series A investment round to strengthen its international position in the world of healthcare data and also to support the team’s growth. It is the largest Belgian investment round ever within the digital health sector. Swiss health tech investor MTIP led the investment round, along with Elaia (FR) and previous investors Heran Partners (BE), Btov Partners (DE) and PMV (BE). PMV previously participated via a convertible loan.